Cholestyramine Light Generic Name & Formulations
Legal Class
Rx
General Description
Cholestyramine resin (as Cl) 4g; per 5g packet or scoop; contains phenylalanine.
Pharmacological Class
Bile acid sequestrant.
See Also
How Supplied
Contact supplier.
Manufacturer
Cholestyramine Light Indications
Indications
Hypercholesterolemia alone or with hypertriglyceridemia resistant to dietary management. Reduction in risk of coronary heart disease. Pruritus due to partial biliary obstruction.
Cholestyramine Light Dosage and Administration
Adult
Initially 1 packet or scoop mixed with fluid or food 1–2 times daily. Maintenance: 2–4 packets or scoops divided into 2 doses; max 6 packets or scoops daily. Increase at 4 week intervals.
Children
See full labeling.
Cholestyramine Light Contraindications
Contraindications
Complete biliary obstruction.
Cholestyramine Light Boxed Warnings
Not Applicable
Cholestyramine Light Warnings/Precautions
Warnings/Precautions
Obtain baseline serum cholesterol, LDL-C, and triglycerides, and monitor during therapy. May need Vit. A, D, K, and folic acid supplementation with long-term therapy. Exclude secondary causes of hypercholesterolemia (e.g., hypothyroidism, diabetes, nephrotic syndrome, dysproteinemias, obstructive liver disease, alcoholism). Favorable trend in cholesterol reduction usually occurs within 1 month; continue therapy to sustain reduction. Phenylketonuria (Light formulation). Constipation. Hemorrhoids. Pregnancy. Nursing mothers.
Cholestyramine Light Pharmacokinetics
See Literature
Cholestyramine Light Interactions
Interactions
Inhibits absorption of phenylbutazone, warfarin, chlorothiazide, propranolol, tetracycline, penicillin G, phenobarbital, thyroid drugs, digitalis, many others; give other drugs 1–2 hours before or 4–6 hours after. Additive effects with HMG-CoA reductase inhibitors, nicotinic acid.
Cholestyramine Light Adverse Reactions
Adverse Reactions
Constipation, fecal impaction, aggravation of hemorrhoids, GI disturbances, osteoporosis, Vit. A, D, K, or folic acid deficiencies, increased bleeding, hyperchloremic acidosis, rash, oral or anal irritation.
Cholestyramine Light Clinical Trials
See Literature
Cholestyramine Light Note
Notes
Formerly known under the brand name Questran Light.
Cholestyramine Light Patient Counseling
See Literature